Results 171 to 180 of about 20,811 (229)

New isoquinolines as potential bronchodilator agents

Tetrahedron, 1973
Abstract The syntheses of 5-hydroxy-6-hydroxymethyl, 6-hydroxy-7-hydroxymethyl and 7-hydroxy-6-hydroxymethyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolines ( 1d ), ( 1b ) and ( 1c ) respectively, are described.
S.F. Dyke, A.W.C. White, D. Hartley
openaire   +1 more source

Humidification, Nebulization, and Bronchodilator Agents

1978
These defense mechanisms include: (a) ciliary escalator system—the mucus carpet carrying microorganisms and small foreign particles at a normal rate of about 1 cm/min from bronchioles and bronchi to the larynx entrance, (b) coughing, and (c) phagocytosis—macrophages in alveoli clearing via interstitial spaces (lymphatics) and upward via the ciliary ...
openaire   +1 more source

In vitro studies on the relative potency of bronchodilator agents

Lung, 1985
This study describes a rapid in vitro assay for the order of potency of bronchodilator drugs using specific binding of (−)-[3H] dihydroalprenolol ([3H]DHA) to rat lung membranes. Under linear conditions with respect to tissue, specific binding of [3H]DHA showed saturability, rapid kinetics of association and dissociation of radioligand, and ...
J H, Fleisher, J L, Pinnas
openaire   +2 more sources

[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2004
Poor clearance of airway secretions contributes to the pulmonary disease in cystic fibrosis (CF). Bronchodilator therapy might benefit in CF, but the efficacy is controversial. Effects of mucolytic agents have not been demonstrated conclusively. Only, efficacy of recombinant human deoxyribonuclease (rhDNase) is established with a rapid onset of benefit.
P, Le Roux, B, Le Luyer
openaire   +1 more source

Bronchodilating Agents

Acta Clinica Belgica, 1985
openaire   +2 more sources

Tricyclic quinuclidylidenes as potential antihistamine-bronchodilating agents

Journal of Medicinal Chemistry, 1975
F J, Villani, T A, Mann, E A, Wefer
openaire   +2 more sources

Aerosols, Bronchodilators and Mucolytic Agents

Anesthesiology, 1962
Frank W. Lovejoy, Paul E. Morrow
openaire   +1 more source

[Measurement of the effect of a bronchodilator agent].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1990
Response in a bronchodilator must be expressed by the combining the largest amplitude of response with the highest reproducibility. The forced expiratory volume in the first second (FEV1) meets these conditions and thus represents the best test. The bronchodilator response is commonly expressed in percent of the initial FEV1.
openaire   +1 more source

Sympathomimetic agents and bronchodilators

1979
D. E. Hathway, L. G. Dring, P. Millburn
openaire   +1 more source

SC-10049: A CATECHOLAMINE BRONCHODILATOR AND HYPERGLYCEMIC AGENT

The Journal of Pharmacology and Experimental Therapeutics, 1961
C G, VAN ARMAN, L M, MILLER, M P, O'MALLEY   +2 more
openaire   +2 more sources